evekhm/cms_iom_500 huggingface dataset:
Article - Blepharoplasty - Medical Policy Article (A52837)
CMS National Coverage PolicyN/AArticle TextAbstract:Blepharoplasty may be defined as any eyelid surgery that improves abnormal function, reconstructs deformities, or enhances appearance and may be either reconstructive or cosmetic (aesthetic). Surgery of the upper eyelids is reconstructive when it provides functional vision and/or visual field benefits or improves the functioning of a malformed or degenerated body member, but cosmetic when done to enhance aesthetic appearance.Medicare does not cover cosmetic surgery or expenses incurred in connection with such surgery(CMS Publication 100-02,Medicare Benefit Policy Manual, Chapter 16, Section 20). This medical policy article specifies covered indications, limitations of coverage, and documentation requirements for non-cosmetic blepharoplasty surgery.Upper blepharoplasty and/or repair of blepharoptosis may be considered functional in nature when excess upper eyelid tissue or the upper lid position produces functional complaints. Those functional complaints are usually related to visual field impairment in primary gaze and/or down gaze (e.g., reading position). The visual impairment is commonly related to a lower than normal position of the eyelid relative to the pupil and/or to excess skin that hangs over the edge of the eyelid. Upper blepharoplasty may also be indicated for chronic dermatitis due to redundant skin and for patients with an anophthalmic socket who are experiencing prosthesis difficulties. Brow ptosis may also produce or contribute to functional visual field impairment. Either or both of these procedures may be required in some situations when a blepharoplasty would not result in a satisfactory functional repair. Similarly, surgery of the lower eyelids is reconstructive when poor eyelid tone (with or without entropion or ectropion) causes dysfunction of the lacrimal pump, lid retraction, and/or exposure keratoconjunctivitis that often results in epiphora (tearing).Definitions:Dermatochalasis:excess skin with loss of elasticity that is usually the result of the aging process.Blepharochalasis:excess skin associated with chronic recurrent eyelid edema that physically stretches the skin.
Article - Blepharoplasty - Medical Policy Article (A52837)
Definitions:Dermatochalasis:excess skin with loss of elasticity that is usually the result of the aging process.Blepharochalasis:excess skin associated with chronic recurrent eyelid edema that physically stretches the skin.Blepharoptosis:drooping of the upper eyelid which relates to the position of the eyelid margin with respect to the eyeball and visual axis.Pseudoptosis:false ptosis, for the purposes of this policy, describes the specific circumstance when the eyelid margin is usually in an appropriate anatomic position with respect to the eyeball and visual axis but the amount of excessive skin from dermatochalasis or blepharochalasis is so great as to overhang the eyelid margin and create its own ptosis. Other causes of pseudoptosis, such as hypotropia and globe malposition, are managed differently and do not apply to this policy. Pseudoptosis resulting from insufficient posterior support of the eyelid, as in phthisis bulbi, microphthalmos, congenital or acquired anophthalmos, or enophthalmos is often correctable by prosthesis modification when a prosthesis is present, although persistent ptosis may be corrected by surgical ptosis repair.Brow Ptosis:drooping of the eyebrows to such an extent that excess tissue is pushed into the upper eyelid. It is recognized that in some instances the brow ptosis may contribute to significant superior visual field loss. It may coexist with clinically significant dermatochalasis and/or lid ptosis.Horizontal Eyelid Laxity:poor eyelid tone, usually a result of the aging process, that causes (1) lid retraction without frank ectropion formation but with corneal exposure and irritation (foreign body sensation) and (2) dysfunction of the eyelid lacrimal pump, both of which result in symptomatic tearing (epiphora).Indications and Limitations:The conditions listed under 2 and 3 below are generally considered reconstructive and usually not subject to the medical review of conditions listed under 1 which have the potential of being considered cosmetic.Blepharoplasty may be considered reconstructive when performed for one of the following conditions that may affect both upper and lower eyelids.To correct visual impairment caused by:
Article - Blepharoplasty - Medical Policy Article (A52837)
Blepharoplasty may be considered reconstructive when performed for one of the following conditions that may affect both upper and lower eyelids.To correct visual impairment caused by:Dermatochalasis, including symptomatic redundant skin weighing down on the upper eyelashes (i.e., pseudoptosis) and surgically induced dermatochalasis after ptosis repair.Blepharochalasis.Blepharoptosis, including dehiscence of the aponeurosis of the levator palpebrae superioris muscle after trauma or cataract extraction, causing ptosis that may obstruct the superior visual field as well as the visual axis in downgaze (reading position).Brow ptosis. It is recognized that brow ptosis repair, in addition to blepharoplasty and/or blepharoptosis repair, may be necessary in some cases to provide an adequate functional result.Any procedure(s) involving blepharoplasty and billed to this contractor must be supported by documented patient complaints which justify functional surgery. This documentation must address the signs and symptoms commonly found in association with ptosis, pseudoptosis, blepharochalasis and/or dermatochalasis. These include (but are not limited to):Significant interference with vision or superior or lateral visual field, (e.g., difficulty seeing objects approaching from the periphery);Difficulty reading due to superior visual field loss; or,Looking through the eyelashes or seeing the upper eyelid skin.The visual fields should demonstrate a significant loss of superior visual field and potential correction of the visual field by the proposed procedures(s). A minimum 12 degree or 30 percent loss of upper field of vision with upper lid skin and/or upper lid margin in repose and elevated (by taping of the lid) to demonstrate potential correction by the proposed procedure or procedures is required. Photographs should also demonstrate the eyelid abnormality(ies) necessitating the procedures(s). (Please see Documentation Requirements.)
Article - Blepharoplasty - Medical Policy Article (A52837)
Please note that in the case of prosthetic difficulties associated with an anophthalmic, microphthalmic, or enophthalmic socket, subjective complaints, examination findings (signs), and failure of prosthesis modification (when indicated) must be documented, along with photographic documentation demonstrating the contribution of one of the above mentioned orbital and/or globe abnormalities as they relate to the abnormal upper and/or lower eyelid position and intolerance of prosthesis wear. (Please see Documentation Requirements below.)Repair of anatomical or pathological defects, including those caused by disease (including thyroid dysfunction and cranial nerve palsies), trauma, or tumor-ablative surgery. Surgery is performed to reconstruct the normal structure of the eyelid, using local or distant tissue. Reconstruction may be necessary to protect the eye and/or improve visual function. Conditions that may require blepharoplasty, ptosis repair, ectropion repair, or entropion repair are:Ectropion and entropionEpiblepharon*Post-traumatic defects of the eyelidPost-surgical defects after excision of neoplasm(s)LagophthalmosCongenital lagophthalmos*Congenital ectropion, entropion*Congenital ptosis*Lid retraction or lag (due to horizontal lower eyelid laxity without ectropion or entropion, causing exposure keratopathy and/or epiphora; due to horizontal upper eyelid laxity, causing floppy eyelid syndrome; or due to orbital thyroid disease).Chronic symptomatic dermatitis of pretarsal skin caused by redundant upper eyelid skin.The medical record must contain documented patient complaints and pertinent examination findings to justify the medical necessity for functional, restorative procedures(s) for the treatment of any of the above conditions. In addition, photographic documentation must demonstrate the clinical abnormality(ies) consistent with the beneficiarys subjective complaint(s) for asterisked (*) diagnoses listed above.
Article - Blepharoplasty - Medical Policy Article (A52837)
Relief of eye symptoms associated with blepharospasm. Primary essential (idiopathic) blepharospasm is characterized by severe squinting, secondary to uncontrollable spasms the peri-ocular facial muscles. Occasionally, it can be debilitating. If other treatments have failed or are contraindicated, a blepharoplasty combined with limited myectomy may be necessary.Patient complaints and relevant medical history (e.g., failure to respond to botulinum toxin therapy, botulinum toxin therapy is contraindicated, etc.) must be documented and available upon request. Please see Documentation Requirements.Documentation Requirements:The patient's medical record must contain documentation that fully supports the medical necessity for services included within this article. (Please see "Indications and Limitations of Coverage.") This documentation includes, but is not limited to, relevant medical history, physical examination, and results of pertinent diagnostic tests or procedures. This documentation must be submitted upon request. In addition, for the Group 2 CPT codes, documentation should consist of visual field results and/or photographs as specified below.Visual fields must be recorded using either a tangent screen visual field, Goldmann Perimeter (III 4-E test object), or a programmable automated perimeter, equivalent to a screening field with a single intensity strategy using a 10dB stimulus, to test a superior (vertical) extent of 50-60 degrees above fixation with targets presented at a minimum four-degree vertical separation starting at zero (0) degrees above fixation while using no wider than a 10-degree horizontal separation.
Article - Blepharoplasty - Medical Policy Article (A52837)
Each eye should be tested with the upper eyelid at rest and repeated with the lid elevated (e.g., taped or manually retracted) to demonstrate an expected surgical improvement meeting or exceeding the criteria. As previously stated, visual fields must demonstrate a minimum 12 degrees or 30 percent loss of upper field of vision with upper lid skin and/or upper lid margin in repose and elevated (by taping of the lid) to demonstrate potential correction by the proposed procedure or procedures.Visual field studies must contain the beneficiarys name, the date, and the eye tested. If the skin edge is below the true eyelid margin, the visual field must be performed with the excess skin untaped and taped (or otherwise retracted).Should there be ptosis in isolation or concurrent with dermatochalasis, the visual fields should be repeated with the true eyelid taped such that the eyelid margin assumes the anatomic position.Visual fields are not required when the reason for the lid surgery is entropion or ectropion.Photographs (prints, not slides) must be frontal and canthus-to-canthus with the head perpendicular to the plane of the camera (i.e., not tilted) in order to demonstrate the position of the true lid margin or the false lid margin in the case of pseudoptosis caused by severe dermatochalsis. The photographs must be of sufficient clarity to show a light reflex on the cornea or the relationship of the eyelid to the cornea or pupil (except in cases where the lid margin obscures the corneal light reflex or a digital camera is used and there is no light reflex).Photographs for the purpose of justifying an eyelid procedure(s) and/or brow ptosis procedures due to superior visual field loss must demonstrate that the upper eyelid margin approaches to within 2.5 mm (1/4 of the diameter of the visible iris) of the corneal light reflex. Specific photograph requirements are described below.Blepharoplasty must portray both eyelids in the frontal (straight-ahead) position demonstrating:
Article - Blepharoplasty - Medical Policy Article (A52837)
Blepharoplasty must portray both eyelids in the frontal (straight-ahead) position demonstrating:Upper eyelid skin resting on the eyelashes or over the eyelid margin; or,Excessive dermatochalasis pushing the eyelid margin down to an abnormally low position; or,One of the above in cases of the induction of visually compromising dermatochalasis after ptosis repair in patents having a large dehiscence of the levator aponeurosis. In addition, an operative note documenting the skin excess after the ptosis has been repaired, and that blepharoplasty is indicated for its repair, is also required.Blepharoptosis repair must portray both eyelids in the frontal (straight-ahead) position demonstrating:True lid ptosis;The upper eyelid position with respect to a prosthesis in an anophthalmic socket or to the globe in congenital or acquired microphthalmos or in enophthalmos.Blepharoptosis repair and blepharoplasty must portray both eyelids in the frontal (straight-ahead) position demonstrating:Presence of true lid ptosis when excessive skin is elevated by taping or is otherwise retracted, especially if it lies below the position of the true eyelid margin. Oblique or lateral photographs may be required to demonstrate redundant skin on the eyelashes.Brow ptosis (performed singly or in combination with other procedures) must be frontal demonstrating:Drooping of brows below the superior orbital rim; and,Improvement of blepharoptosis and/or dermatochalasis by elevation of the brows. (Note: If a blepharoplasty and/or lid ptosis repair and/or brow ptosis are planned, the necessity for each individual procedure performed and billed to Medicare must be documented and supported by photographs. This may require multiple sets of photographs (and/or visual fields), showing the effect of drooping of redundant skin (and its correction by taping or manual retraction) and the actual presence of blepharoptosis and/or brow ptosis and/or an eyelid dermatitis.If the patients only complaint is obstruction of vision when reading, two photographs are obtained to demonstrate the eyelid position in primary gaze (straight ahead) and downgaze (visual axis and camera lens coaxial), demonstrating:
Article - Blepharoplasty - Medical Policy Article (A52837)
If the patients only complaint is obstruction of vision when reading, two photographs are obtained to demonstrate the eyelid position in primary gaze (straight ahead) and downgaze (visual axis and camera lens coaxial), demonstrating:The eyelid position in primary gaze (straight ahead) and down gaze (visual axis and camera lens coaxial); and,The subjective complaints of the beneficiary must be well documented in the medical record as well as the medical and/or surgical history supporting eyelid dysfunction. For instance, many patients may not have problems until after fatigue and/or may have more problems in the afternoon compared to the morning.In cases of induction of visually compromising dermatochalasis by ptosis repair in patients having large dehiscence of the levator aponeurosis documentation must demonstrate:Dehiscence of the levator aponeurosis; andAn operative note indicating the skin excess after the ptosis has been repaired and blepharoplasty is necessary.
Article - Blepharoplasty - Medical Policy Article (A52837)
Dehiscence of the levator aponeurosis; andAn operative note indicating the skin excess after the ptosis has been repaired and blepharoplasty is necessary.Coding Information:Procedure codes may be subject to National Correct Coding Initiative (NCCI) edits or OPPS packaging edits. Refer to NCCI and OPPS requirements prior to billing Medicare.For services requiring a referring/ordering physician, the name and NPI of the referring/ordering physician must be reported on the claim.The diagnosis code(s) must best describe the patient's condition for which the service was performed.A claim submitted without a valid ICD-10-CM diagnosis code will be returned to the provider as an incomplete claim under Section 1833(e) of the Social Security Act.Advance Beneficiary Notice of Noncoverage (ABN) Modifier GuidelinesAn ABN may be used for services which are likely to be non-covered, whether for medical necessity or for other reasons. Refer to CMS Publication 100-04, Medicare Claims Processing Manual,Chapter 30, for complete instructions.Specific coding information for this article:The relevant anatomic modifier or the modifier 59 (distinct procedural services) should be used for procedures at different sites.Appropriate anatomic modifiers for procedure codes 15820-15823 and 67901-67924 are E1 (upper left, eyelid), E2 (lower left, eyelid), E3 (upper right eyelid), and E4 (lower right, eyelid).Brow repair and eyelid procedures performed during the same operative session are subject to multiple surgery guidelines as listed in the Medicare Physician Fee Schedule.When visual fields are done, bill one unit of service per date of service, even if multiple studies are performed.Please see the Documentation Requirements for further instructions for the Part A MAC. The physicians interpretation of the visual fields and the description of the photographic findings may be included in Form Locator 80 of the UB-04 or its electronic equivalent.CMS National Coverage Policy
Article - Blepharoplasty - Medical Policy Article (A52837)
Title XVIII of the Social Security Act (SSA):Section 1862(a)(1)(A) excludes expenses incurred for items or services which are not reasonable and necessary for the diagnosis or treatment of illness or injury or to improve the functioning of a malformed body member.Section 1833(e) prohibits Medicare payment for any claim which lacks the necessary information to process the claim.Section 1862(1)(10) prohibits payment for cosmetic surgery. Procedures performed only to approve appearances without a functional benefit are not covered by Medicare.CMS Publications:CMS Publication 100-02,Medicare Benefit Policy Manual,Chapter 16:20.2.1 Categorical Denials120 Cosmetic Surgery
Article - Investigational Device Exemption Requests - Medical Policy Article (A52841)
CMS National Coverage PolicyN/AArticle TextClinical Study RequestCompliance with the instructions contained in the Medicare Claims Processing Manual (Publication 100-04, chapter 32, sections 68 and 69) is a requirement for both National Government Services and our providers. Providers are required to notify Medicare about clinical studies under four conditions:Effective for dates of service on or after January 1, 2015, providers that participate in an IDE clinical study may file claims for CMS category B IDEs approved by CMS (or its designated entity) and listed on the CMS Coverage Website. This applies to all IDEs assigned an identifying number beginning with a G and a CMS category B (B1, B2, B3, or B4) by the Food and Drug Administration (FDA).Effective for dates of service on or after January 1, 2015, Institutional providers and practitioners shall submit claims only for routine care items and services in Category A IDE device studies approved by CMS (or its designated entity) and listed on the CMS Coverage Website.Effective for dates of service on or after January 1, 2015, providers participating in post-market approval studies or registries of carotid stents may file claims for studies approved by CMS (or its designated entity) and listed on the CMS Coverage Website.Effective for dates of service on or after January 1, 2015, poviders participating in studies for proximal embolic protection devices (EPDs) in carotid artery stenting (CAS) procedures may file claims for studies approved by CMS (or its designated entity) and listed on the CMS Coverage Website.Effective for Category A and B IDE studies approved by the FDA on or after January 1, 2015, interested parties (i.e., study sponsors) that wish to seek Medicare coverage in Category A or B IDE studies must submit a request for review and approval via email to clinicalstudynotification@cms.hhs.gov or via hard copy to the following address:Centers for Medicare and Medicaid Services Center for Clinical Standards and Quality Director, Coverage and Analysis Group ATTN: Clinical Study CertificationMail Stop: S3-02-017500 Security Blvd. Baltimore, MD 21244
Article - Investigational Device Exemption Requests - Medical Policy Article (A52841)
Centers for Medicare and Medicaid Services Center for Clinical Standards and Quality Director, Coverage and Analysis Group ATTN: Clinical Study CertificationMail Stop: S3-02-017500 Security Blvd. Baltimore, MD 21244National Government Services will review renewal or modified clinical study requests from hospitals and physicians in Connecticut, Illinois, Maine, Massachusetts, Minnesota, New Hampshire, New York, Rhode Island, Vermont, and Wisconsin. Clinical coverage determinations are applied uniformly across these regions. If a study has been reviewed for another facility you may not be required to submit study specific information. To reduce the amount of information you are required to submit, please send the following inquiry to National Government Services electronically prior to submitting a request for authorization.Send email to: NGS-IDE-Request@wellpoint.com OR fax to 315-442-4257.E-mail or FAX Subject line should include the type of request (Renewal or Modifications) and the IDE Number.
Article - Local Coverage Determination (LCD) Reconsideration Process - Medical Policy Article (A52842)
CMS National Coverage PolicyN/AArticle TextThe requirements in this article are based on instructions found in CMS Publication 100-08,Medicare Program Integrity Manual, Chapter 13, Section 13.3.1, 13.3.2 and 13.3.3.Reconsideration Request ProcessThe LCD reconsideration process is a mechanism by which a beneficiary or stakeholder (including a medical professional society or physician) in NGS jurisdiction can request a revision to an LCD. The LCD reconsideration process differs from an initial request for an LCD in that it is available only forfinal, effective LCDs. The whole LCD or any provision of the LCD may be reconsidered.Reconsideration Requests May Be Submitted ByNational Government Services will consider all LCD reconsideration requests from:Beneficiaries residing or receiving care in[our]jurisdiction(Alaska, American Samoa, Arizona, California, Connecticut, Guam, Hawaii, Illinois, Idaho, Maine, Massachusetts, Michigan, Minnesota, Nevada, New Hampshire, New Jersey, New York, Northern Mariana Islands, Oregon, Puerto Rico, Rhode Island, Vermont, U. S. Virgin Islands, Virginia, Washington, West Virginia and Wisconsin);Providers doing business in[our]jurisdictionAny interested party doing business in[our]jurisdiction.Acceptable RequestsThe LCD Reconsideration Process is available only for final, effective LCDs. The whole LCD or any provision of the LCD may be reconsidered.Unacceptable RequestsRequests are not accepted for other documents including:National Coverage Determinations (NCDs)Coverage provisions in interpretive manualsProposed LCDs;Template LCDs, unless or until they are adoptedand in effectby the contractor;Retired LCDs;Individual claim determinations;Bulletins, articles, training materials; andAny instance in which no LCD exists,i.e, requests for development of an LCD.Submission Documentation RequirementsRequests must be submitted in writing and include the following items: name and address of beneficiary or provider; orif the requestor is neither a beneficiary, nor a provider, the name and address of the organization he/she represents and the nature of that organization's businesse-mail address (preferred);telephone number (optional)the name of the final, effective LCD, andcopies of published evidence, andlanguage wanted to be added to or deleted from the LCD.